glp-1 drug coverage America's Poison Centers GLP-1 Medications for Weight Loss:

Following a similar dosing schedule, one study showed that people were able to lose an average of about 5% of their body weight over 6 months

Blue Cross and BCN will continue covering GLP-1s prescribed to treat Type 2 diabetes, including the medications Ozempic, Mounjaro, Rybelsus and Victoza

Notably, no significant correlation was observed between the duration of GLP-1RAs discontinuation and the prevalence of retained gastric contents, although a trend toward reduced retention with longer discontinuation was noted

Animal data on a GLP-1/GIP/glucagon triple agonist show strong effects on body weight reduction, and glucose- and lipid normalization in rodents

Dahifale A, Agnihotri TG, Jain A, Jain A